Genetics, bioethics and sport

Sport, Ethics and Philosophy

Volumn 1, Issue 2, 2007, Pages 146-158

  Miah, Andy ^a  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

Bioethics; Genetics; Human enhancement; Sport

Indexed keywords

EID: 85009648972     PISSN: 17511321     EISSN: 1751133X     Source Type: Journal    
DOI: 10.1080/17511320701425181     Document Type: Article

References (55)

1. AAAS (AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE). 2003. Bigger, faster, stronger: Genetic enhancement and athletics. Symposium at annual meeting, 18 Feb., Denver, CO. Available at http://health.ucsd.edu/news/2003/02_18_Friedmann.html, accessed 7 June 2007.
2. AUSTRALIA LAW REFORM COMMISSION. 2001. Protection of human genetic information-12. Other services and contexts. Issues paper 26, available at http://www.austlii.edu.au/au/other/alrc/publications/issues/26/, accessed 7 June 2007.
3. AUSTRALIA LAW REFORM COMMISSION. 2003. ALRC 96: Essentially Yours. Sydney: Australian Law Reform Commission of the Australian National Government.
4. BAILEY, C.I. 1980. Sport and the element of chance. Journal of Sport Behaviour 3 (2): 69-75.
5. BAKER, A. and W.G. HOPKINS. 1998. Altitude training for sea-level competition. Sportscience: Training & Technology. Internet Society for Sport Science, available at http://sportsci.org/traintech/altitude/wgh.html, accessed 7 June 2007.
6. BARTON-DAVIS, E.R., D.I. SHOTURMA, A. MUSARO, N. ROSENTHAL and H.L. SWEENEY. 1998. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proceedings of the National Academy of Sciences (USA) 95: 15603-7.
7. BOYD, K.M. 2000. Disease, illness, sickness, health, healing and wholeness: Exploring some elusive concepts. Journal of Medical Ethics: Medical Humanities 26 (1): 9-17.
8. BROCK, D.W. 1998. Enhancements of human function: Some distinctions for policymakers. In Enhancing Human Traits: Ethical and Social Implications, edited by E. Parens. Washington, DC: Georgetown University Press: 48-69.
9. BROWN, W.M. 1980. Ethics, drugs and sport. Journal of the Philosophy of Sport VII: 15-23.
10. BRULL, D., S. DHAMRAIT, S. MYERSON, J. ERDMANN, V. REGITZ-ZAGROSEK, M. WORLD, D. PENNELL, S.E. HUMPRHIES and H. MONTGOMERY. 2001. Bradykinin B2bkr receptor polymorphism and left-ventricular growth response. The Lancet 358 (6 Oct.): 1155-6.
11. CHADWICK, R.F. 1987. Having children: Introduction. In Ethics, Reproduction and Genetic Control, edited by R.F. Chadwick. London: Routledge: 3-43.
12. COLE-RURNER, R. 1998. Do means matter? In Enhancing Human Traits: Ethical and Social Implications, edited by E. Parens. Washington, DC: Georgetown University Press: 151-61.
13. DUBIN, C.L. 1990. Commission of Inquiry into the Use of Drugs and Banned Practices Intended to Increase Athletic Performance. Ottawa: Canadian Government Publishing Centre.
14. FOST, N. 1986. Banning drugs in sports: A skeptical view. Hastings Center Report 16: 5-10.
15. GAYAGAY, GEORGE., BING. YU, BRETT. HAMBLY, TANYA. BOSTON, ALAN. HAHN, DAVID S. CELERMAJER and R. J. TRENT. 1998. Elite endurance athletes and the Ace I Allele-the role of genes in athletic performance. Human Genetics 103 (1): 48-50.
16. GLOVER, J. 1984. What Sort of People Should There Be? Harmondsworth: Penguin.
17. GOLDSPINK, G. 2001. Gene expression in skeletal muscle. Biochemical Society Transactions 30: 285-90.
18. HOBERMAN, J.M. 1992. Mortal Engines: The Science of Performance and the Dehumanization of Sport. New York: The Free Press (reprinted 2001, The Blackburn Press)
19. HOULIHAN, B. 1999. Dying to Win: Doping in Sport and the Development of Anti-Doping Policy. Strasburg: Council of Europe Publishing.
20. HOULIHAN, B. 2004. Civil rights, doping control and the world anti-doping code. Sport in Society 7 (3): 420-37.
21. INTERNATIONAL OLYMPIC COMMITTEE. 2001. IOC Gene Therapy Working Group-Conclusion. Press release, International Olympic Committee, Lausanne, available at http://www.olympic.org/uk/news/publications/press_uk.asp?release1/4179, accessed 7 June 2007.
22. JUENGST, E.T. 1998. What does enhancement mean? In Enhancing Human Traits: Ethical and Social Implications, edited by E. Parens. Washington, DC: Georgetown University Press: 29-47.
23. KANE, D. 2004. Athletics, genetic enhancement and ethics. American Association for the Advancement of Science press release, available at http://www.aaas.org/news/releases/2004/0224athalete.shtml, accessed 7 June 2007.
24. LAMSAM, C., F.H. FU, P.D. ROBBINS and C.H. EVANS. 1997. Gene therapy in sports medicine. Sports Medicine 25 (2): 73-7.
25. LEDLEY, F.D. 1994. Distinguishing genetics and eugenics on the basis of fairness. Journal of Medical Ethics 20: 157-64.
26. LEE, S., E.R. BARTON, H.L. SWEENEY and R.P. FARRAR. 2004. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. Journal of Applied Physiology 96: 1097-1104.
27. LEVINE, B.D. 2006. Editorial: should ‘artificial’ high altitude environments be considered doping? Scandinavian Journal of Medicine and Science in Sports 16: 297-301.
28. LIN, J., H. WU, P.T. TARR, C. ZHANG, Z. WU, O. BOSS, L.F. MICHAEL, P. PUIGSERVER, E. ISOTANI, E.N. OLSON, B.B. LOWELL, R. BASSEL-DUBY and B.M. SPIEGELMANN. 2002. Transcriptional co-activator Pgc-1 drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
29. LITTLE, M.O. 1998. Cosmetic surgery, suspect norms, and the ethics of complicity. In Enhancing Human Traits: Ethical and Social Implications, edited by E. Parens. Washington, DC: Georgetown University Press: 162-76.
30. LOLAND, S. 2002. Fair Play in Sport: A Moral Norm System. London and New York: Routledge.
31. MACINTYRE, A. 1985. After Virtue: A Study in Moral Theory. 2nd edn. London: Duckworth.
32. MCCRORY, P. 2001. Ethics, molecular biology, and sports medicine. British Journal of Sports Medicine 35 (3): 142-3.
33. MCKENNY, G.P. 1998. Enhancements and the ethical significance of vulnerability. In Enhancing Human Traits: Ethical and Social Implications, edited by E. Parens. Washington, DC: Georgetown University Press: 222-37.
34. MAGDALINSKI, T. 2000. Performance technologies: Drugs and Fastskin at the Sydney 2000 Olympics. Media International Australia 97 (Nov.): 59-69.
35. MARTINEK, V., F.H. FU and J. HUARD. 2000. Gene therapy and tissue engineering in sports medicine. The Physician and Sports Medicine 28 (2), available at http://www.physsportsmed.com/issues/2000/02_00/huard.htm, accessed 7 June 2007.
36. MIAH, A. 2004. Genetically Modified Athletes: Biomedical Ethics, Gene Doping and Sport. London and New York: Routledge.
37. MONTGOMERY, H., R. MARSHALL, H. HEMINGWAY, S. MYERSON, P. CLARKSON, C. DOLLERY, M. HAYWARD, D.E. HOLLIMAN, M. JUBB, M. WORLD, E.L. THOMAS, A.E. BRYNES, N. SAEED, M. BARNARD, J.D. BELL, K. PRASAD, M. RAYSON, P.J. TALMUD and S.E. HUMPHRIES. 1998. Human gene for physical performance. Nature 393 (21): 221-2.
38. MONTGOMERY, H., P. CLARKSON, M. BARNARD, J. BELL, A. BRYNES, C. DOLLERY, J. HAJNAL, H. HEMINGWAY, D. MERCER, P. JARMAN, R. MARSHALL, K. PRASAD, M. RAYSON, N. SAEED, P. TALMUD, L. THOMAS, M. JUBB, M. WORLD and S. HUMPHRIES. 1999. Angiotensin-converting-enzyme gene insertion/ deletion polymorphism and response to physical training. The Lancet 353 (13): 541-5.
39. MORGAN, W.J. 1994. Leftist Theories of Sport: A Critique and Reconstruction. Urbana, IL: University of Illinois Press.
40. MURRAY, T.H. 1983. The coercive power of drugs in sports. Hastings Center Report (August): 24-30.
41. MURRAY, T.H. 1984. Drugs, sports, and ethics. In Feeling Good and Doing Better, edited by T.H. Murray, W. Gaylin and R. Macklin. Clifton, NJ: Humana Press: 107-26.
42. PARENS, E. 1995. The goodness of fragility: On the prospect of genetic technologies aimed at the enhancement of human capacities. Kennedy Institute of Ethics Journal 5 (2): 141-53.
43. PARENS, E., ed. 1998. Enhancing Human Traits: Ethical and Social Implications. Washington, DC: Georgetown University Press.
44. RANKINEN, T., M.S. BRAY, J.M. HAGBERG, L. PÉRUSSE, S.M. ROTH, B. WOLFARTH and C. BOUCHARD. 2006. The human gene map for performance and health-related fitness phenotypes: The 2005 update. Medicine and Science in Sport & Exercise 38 (11): 1863-88.
45. SADE, R.M. 1995. A theory of health and disease: The objectivist-subjectivist dichotomy. Journal of Medicine and Philosophy 20 (5): 513-25.
46. SIMON, R.L. 1991. Fair Play: Sport, Values, and Society. Boulder, CO: Westview Press.
47. SODERBERG, W. 1998. Genetic enhancement of a child’s memory: A search for a private and public morality. Paper presented at the 20th World Congress of Philosophy, Boston, MA.
48. SVENSSON, E.C., H.B. BLACK, D.L. DUGGER, S.K. TRIPATHY, E. GOLDWASSER, Z. HAO, L. CHU and J.M. LEIDEN. 1997. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Human Gene Therapy 8 (15): 1797-1806.
49. TAMBURRINI, C. and T. TÄNNSJÖ, eds. 2005. Genetic Technology and Sport: Ethical Questions, Ethics and Sport. Abingdon and New York: Routledge.
50. TURNER, L. 2003. Has the President’s Council on Bioethics missed the boat? British Medical Journal 327: 629.
51. US PRESIDENT’S COUNCIL ON BIOETHICS. 2002a. Session 4: Enhancement 2: Potential for Genetic Enhancements in Sports. Washington, DC: The President’s Council on Bioethics (available at http://www.bioethics.gov/transcripts/jul02/session4.html, accessed 7 June 2007)
52. US PRESIDENT’S COUNCIL ON BIOETHICS. 2002b. Sixth Meeting: Session 7: Enhancement 5: Genetic Enhancement of Muscle. Washington, DC: The President’s Council on Bioethics (available at http://www.bioethics.gov/transcripts/sep02/session7.html, accessed 7 June 2007)
53. WORLD ANTI-DOPING AGENCY. 2002. WADA conference sheds light on the potential of gene doping. Press release, World Anti-Doping Agency, New York, available at http://www.wada-ama.org, accessed 7 June 2007.
54. WORLD ANTI-DOPING AGENCY. 2003. International standard for the prohibited list 2004. Available at http://www.wada-ama.org/docs/web/standards_harmonization/code/list_standard_2004.pdf, accessed 7 June 2007.
55. WORLD ANTI-DOPING AGENCY. 2005. The Stockholm Declaration. Montreal: World Anti-Doping Agency.